Target intelligence / Profile preview

Endoplasmic reticulum resident protein 44 (ERp44)

Target
ERp44
Molecular classification
Protein disulfide isomerase family, Thioredoxin-like protein, Enzyme (oxidoreductase/chaperone), Endoplasmic reticulum resident protein
01

Overview

Endoplasmic reticulum resident protein 44 (ERp44) is a multi-domain chaperone and oxidoreductase belonging to the protein disulfide isomerase (PDI) family, localized mainly in the endoplasmic reticulum, ER-Golgi intermediate compartment, and the cis-Golgi. ERp44 plays a key role in oxidative protein folding by forming mixed disulfide bonds with client proteins and regulating their retention or retrieval, thus ensuring quality control during protein maturation and secretion. It contains a thioredoxin-like domain with a unique CRFS active site motif and a C-terminal RDEL motif for ER localization. ERp44 is functionally important in controlling the assembly and maturation of certain secretory proteins (such as immunoglobulin M and adiponectin), and its activity is regulated by pH-dependent conformational changes involving histidine residues. Emerging evidence suggests that PDI family members, including ERp44, are implicated in cancer and neurodegenerative diseases due to their roles in proteostasis and ER stress responses, making them putative therapeutic targets.

Other names
PDIA10TXNDC4KIAA0573protein disulfide isomerase family A member 10thioredoxin domain-containing protein 4ER protein 44ERp44UNQ532/PRO1075
02

Mechanism of action

Redox modulation (mixed disulfide formation with client proteins, retention of immature or misfolded proteins in the ER/Golgi, regulation of ER oxidative folding); pH-dependent client binding/release (ERp44’s structure and binding to clients and receptors is regulated by pH and histidine protonation)

03

Biological functions

Oxidative protein foldingRedox controlChaperone activityQuality control of client proteinsRetention/retrieval of immature or misfolded secretory proteins in the early secretory pathwayInteraction with ER-resident enzymesRegulation of secretory protein assembly (e.g., immunoglobulin M, adiponectin)
04

Disease associations

Cancer (regulates protein folding and ER stress responses, implicated as a therapeutic target in various tumors)Neurodegenerative diseases (as part of unfolded protein response and ER proteostasis)Other (quality control and retention functions suggest roles in diseases related to protein misfolding, but less direct evidence)
05

Safety considerations

None separately documented for ERp44 as a direct drug target; targeting ER redox control proteins may impact proteostasis, potentially leading to off-target effects in protein folding and secretion pathways
06

Interacting drugs

None specifically documented for ERp44 itself as of current literature; inhibitors or modulators typically target broader PDI family members or ER stress pathways. No FDA-approved drugs directly target ERp44.
07

Biomarkers

None established as specific clinical biomarkers; changes in ERp44 expression may reflect ER stress or protein folding status, but not routinely measured in clinic

Beyond the preview

Go deeper on Endoplasmic reticulum resident protein 44 (ERp44).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoplasmic reticulum resident protein 44 (ERp44).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call